查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1618717

基因组编辑中的突变检测试剂套件市场：按基因组、按应用划分 - 2025-2030 年全球预测

Mutation Detection Kits In Genome Editing Market by Genome (CRISPR/Cas9, Meganucleases, TALENs/MegaTALs), End-Use (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因组编辑突变检测套件市场规模为1.928亿美元，预计2024年将达到2.2274亿美元，复合年增长率为15.83%，2030年将达到5.3951亿美元，预计将达到1000万美元。

基因组编辑中的突变检测试剂套件是用于识别基因组编辑过程中产生的 DNA 序列遗传变化的重要工具。这些套件对于医学研究、农业和生物技术的应用至关重要，使科学家能够评估 CRISPR、TALEN 和 ZFN 等基因组编辑技术的效率和准确性。这些套件的需求源于确认编辑成功并确保基因改造生物和实验室编辑细胞的安全性和有效性的需要。这些应用遍及最终用途产业，包括用于药物开发的製药、用于治疗方法开发的临床研究以及用于开发改良作物品种的农业。

主要市场统计
基准年[2023] 1.928 亿美元
预测年份 [2024] 2.2274亿美元
预测年份 [2030] 53951万美元
复合年增长率（%） 15.83%

基因组编辑技术的日益普及、生物技术研究投资的增加以及遗传疾病治疗的进步等因素推动了突变检测套件市场。关键的成长要素包括对个人化医疗的需求不断增长以及遗传疾病的盛行率不断增加，这推动了研究工作。潜在的商业机会在于开发具有成本效益的高通量检测试剂套件，可以促进在资源匮乏的环境中的广泛采用。公司可以透过创新来利用这些机会，以提高准确性、降低成本并简化套件的使用。

该市场面临的挑战包括先进检测试剂套件的高成本以及围绕重组基因技术的监管挑战，这可能会影响市场扩张。此外，对基因组编辑的伦理担忧可能会阻碍广泛接受。技术挑战，例如准确检测小突变的复杂性，使市场成长更加复杂。

需要创新和研究的领域包括携带式检测设备的开发、测试过程的自动化以及与生物资讯工具的整合以增强资料分析。生物技术公司和学术机构之间的合作研究可能会推动进一步的进步。市场的特点是技术发展迅速、竞争激烈，需要不断创新和策略联盟来保持竞争力。利用人工智慧的突破对基因组编辑结果进行预测分析是获得洞察力和实现业务成长的一个有前途的途径。

市场动态：基因组编辑中快速发展的突变检测试剂套件市场的关键市场洞察

供需的动态交互作用正在改变基因组编辑突变检测套件的市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 遗传性疾病和癌症的盛行率不断增加
    • 增加基因研究和个人化医疗的投资
  • 市场限制因素
    • 与基因组编辑技术相关的高成本和复杂的法规
  • 市场机会
    • 定序技术和生物资讯学的创新
    • 生技公司与研究机构之间的合作研究增加
  • 市场挑战
    • 与突变检测试剂套件相关的技术限制和准确性问题

波特的五力：引领基因组编辑突变检测试剂套件市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因组编辑突变检测试剂套件市场的外部影响

外部宏观环境因素在塑造基因组编辑市场突变检测试剂套件的性能动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因组编辑突变检测试剂套件市场的竞争状况

对基因组编辑市场中突变检测试剂套件的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因组编辑突变检测试剂套件市场厂商绩效评估

FPNV定位矩阵是评估基因组编辑突变检测试剂套件市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了基因组编辑突变检测试剂套件市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因组编辑突变检测试剂套件市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传疾病和癌症的发生率增加
      • 增加基因研究和个人化医疗的投资
    • 抑制因素
      • 与基因组编辑技术相关的高成本和复杂的法规
    • 机会
      • 定序技术和生物资讯学的创新
      • 加强生技公司与研究机构的合作
    • 任务
      • 与突变检测试剂套件相关的技术限制和准确性问题
  • 市场区隔分析
    • 基因组学：透过广泛的应用和持续的治疗开发扩大 CRISPR/Cas9 的商业化
    • 最终用途：学术研究机构对开发新型基因编辑技术的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因组编辑的突变检测试剂套件市场基因组

  • 保鲜盒/Cas9
  • Meganucleases
  • TALEN/超级TAL
  • 泽夫

第七章基因组编辑中的突变检测试剂套件市场：依最终用途

  • 学术研究所
  • 生物技术和製药公司
  • 合约调查机构

第八章 北美和南美基因组编辑突变检测试剂套件市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区基因组编辑突变检测试剂套件市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲基因组编辑突变检测试剂套件市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • InnoClass 和 Watchmaker Genomics 宣布建立策略合作伙伴关係，共同开发先进的基因组编辑解决方案
    • FDA核准Prime Medicine 首个 Prime Edit 疗法的 IND
    • Regeneron 和 Mammoth Biosciences 开始在体内 CRISPR 基因编辑方面合作
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Applied Biological Materials, Inc.
  • Bio-Rad Laboratories
  • BIOKE, BV by Cell Signaling Technology, Inc.
  • Bioneer Corporation
  • Biovision Inc. by Abcam Limited
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Launch Diagnostics Limited by Avacta Group Plc
  • LGC Biosearch Technologies
  • Lonza Group AG
  • Medaysis Company
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • New England Biolabs
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Promega Corporation
  • Qiagen NV
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • TRUPCR by Kilpest India Limited
Product Code: MRR-3A2E844FDB57

The Mutation Detection Kits In Genome Editing Market was valued at USD 192.80 million in 2023, expected to reach USD 222.74 million in 2024, and is projected to grow at a CAGR of 15.83%, to USD 539.51 million by 2030.

Mutation detection kits in genome editing are integral tools used to identify genetic alterations in DNA sequences resulting from genome editing processes. These kits are essential for applications in medical research, agriculture, and biotechnology, enabling scientists to assess the efficiency and precision of genome editing technologies such as CRISPR, TALENs, and ZFNs. The necessity of these kits stems from the need to confirm successful edits and ensure the safety and efficacy of genetically modified organisms or lab-edited cells. Their applications extend across end-use industries like pharmaceuticals for drug development, clinical research for therapeutic advancements, and agriculture for developing enhanced crop varieties.

KEY MARKET STATISTICS
Base Year [2023] USD 192.80 million
Estimated Year [2024] USD 222.74 million
Forecast Year [2030] USD 539.51 million
CAGR (%) 15.83%

The market for mutation detection kits is driven by factors such as the increasing adoption of genome editing technologies, rising investments in biotechnology research, and advancements in genetic disease therapies. A key growth influencer is the expanding demand for personalized medicine and the growing prevalence of genetic disorders, which drive research activities. Potential opportunities lie in developing cost-effective, high-throughput detection kits that can facilitate broader adoption in low-resource settings. Companies can capitalize on these opportunities by innovating to improve accuracy, reduce costs, and simplify kit usage.

Limitations in the market include the high cost of sophisticated detection kits and regulatory challenges surrounding genetic modification technologies that can impact market expansion. Additionally, ethical concerns regarding genome editing may hinder widespread acceptance. Technological challenges, such as the complexity of detecting small mutations accurately, further complicate market growth.

Areas ripe for innovation and research include the development of portable detection devices, automation of testing processes, and integration with bioinformatics tools for enhanced data analysis. Collaborations between biotech firms and academic institutions could drive advancements further. The market is characterized by rapid technological developments and increasing competition, necessitating continuous innovation and strategic partnerships to maintain a competitive edge. Leveraging breakthroughs in artificial intelligence for predictive analytics in genome editing outcomes represents a promising avenue for gaining insights and achieving business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of genetic disorders and cancer
    • Rising investments in genetic research and personalized medicine
  • Market Restraints
    • High costs and complex regulations associated with genome editing technologies
  • Market Opportunities
    • Innovations in sequencing technologies and bioinformatics
    • Increasing collaboration between biotech firms and research institutions
  • Market Challenges
    • Technical limitations and accuracy concerns associated with the mutation detection kits

Porter's Five Forces: A Strategic Tool for Navigating the Mutation Detection Kits In Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mutation Detection Kits In Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mutation Detection Kits In Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mutation Detection Kits In Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mutation Detection Kits In Genome Editing Market

A detailed market share analysis in the Mutation Detection Kits In Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mutation Detection Kits In Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mutation Detection Kits In Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mutation Detection Kits In Genome Editing Market

A strategic analysis of the Mutation Detection Kits In Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mutation Detection Kits In Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Applied Biological Materials, Inc., Bio-Rad Laboratories, BIOKE, B.V. by Cell Signaling Technology, Inc., Bioneer Corporation, Biovision Inc. by Abcam Limited, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Launch Diagnostics Limited by Avacta Group Plc, LGC Biosearch Technologies, Lonza Group AG, Medaysis Company, Merck KGaA, Mylab Discovery Solutions Pvt. Ltd., New England Biolabs, New England Biolabs, Inc., Origene Technologies, Inc., Promega Corporation, Qiagen N.V., Synthego Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and TRUPCR by Kilpest India Limited.

Market Segmentation & Coverage

This research report categorizes the Mutation Detection Kits In Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Genome, market is studied across CRISPR/Cas9, Meganucleases, TALENs/MegaTALs, and ZFN.
  • Based on End-Use, market is studied across Academic Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of genetic disorders and cancer
      • 5.1.1.2. Rising investments in genetic research and personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and complex regulations associated with genome editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in sequencing technologies and bioinformatics
      • 5.1.3.2. Increasing collaboration between biotech firms and research institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and accuracy concerns associated with the mutation detection kits
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Genome: Expanding commercialization of CRISPR/Cas9 with broad applications and ongoing therapeutic developments
    • 5.2.2. End-Use: Increasing demand by academic research institutes for development of new gene editing techniques
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mutation Detection Kits In Genome Editing Market, by Genome

  • 6.1. Introduction
  • 6.2. CRISPR/Cas9
  • 6.3. Meganucleases
  • 6.4. TALENs/MegaTALs
  • 6.5. ZFN

7. Mutation Detection Kits In Genome Editing Market, by End-Use

  • 7.1. Introduction
  • 7.2. Academic Research Institutes
  • 7.3. Biotechnology & Pharmaceutical Companies
  • 7.4. Contract Research Organizations

8. Americas Mutation Detection Kits In Genome Editing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Mutation Detection Kits In Genome Editing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Mutation Detection Kits In Genome Editing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Inocras and Watchmaker Genomics announce strategic collaboration to develop advanced genome editing solutions
    • 11.3.2. FDA approves Prime Medicine's IND for first prime editing therapy
    • 11.3.3. Regeneron and Mammoth Biosciences launch collaboration for in vivo CRISPR gene editing
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Amoy Diagnostics Co., Ltd.
  • 3. Applied Biological Materials, Inc.
  • 4. Bio-Rad Laboratories
  • 5. BIOKE, B.V. by Cell Signaling Technology, Inc.
  • 6. Bioneer Corporation
  • 7. Biovision Inc. by Abcam Limited
  • 8. GenScript Biotech Corporation
  • 9. Illumina, Inc.
  • 10. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 11. Launch Diagnostics Limited by Avacta Group Plc
  • 12. LGC Biosearch Technologies
  • 13. Lonza Group AG
  • 14. Medaysis Company
  • 15. Merck KGaA
  • 16. Mylab Discovery Solutions Pvt. Ltd.
  • 17. New England Biolabs
  • 18. New England Biolabs, Inc.
  • 19. Origene Technologies, Inc.
  • 20. Promega Corporation
  • 21. Qiagen N.V.
  • 22. Synthego Corporation
  • 23. Takara Bio Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. TransGen Biotech Co., Ltd.
  • 26. TRUPCR by Kilpest India Limited

LIST OF FIGURES

  • FIGURE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MUTATION DETECTION KITS IN GENOME EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TALENS/MEGATALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023